In the KEGG pathway analysis, EGFR tyrosine kinase inhibitor resistance (hsa01521), Central carbon metabolism in cancer (hsa05230), and PI3K/AKT signaling pathway (hsa04151) became the top three significantly enriched. The gene discussed is EGFR; the disease is cancer.